Serialisation milestone: Recipharm connects to European Hub

As the industry continues its preparations for the European Falsified Medicines Directive (FMD), Recipharm has reached another important milestone in its journey to serialisation compliance.

The process of connecting to the EU Hub should not be underestimated.

The CDMO, with support from strategic partner TraceLink, has successfully received European Medicines Verification Organisation (EMVO) approval to submit serialisation data to the European Hub.

On 6th August, the EMVO stated that only 106 of the EU’s 2000-plus pharmaceutical companies have completed the on-boarding process with their National Medicines Verification Organisations (NMVOs) and developed their connections to the EU Hub.

This project milestone reaffirms Recipharm’s global leadership in serialisation and our commitment to meeting the compliance requirements well ahead of the February 2019 deadline. The news has been covered by industry media including Securing Industry. Read more here.